Tumor size is the most significant risk factor for local recurrence in dermatofibrosarcoma protuberans: A large-scale retrospective cohort analysis

隆突性皮肤纤维肉瘤 医学 回顾性队列研究 皮肤纤维肉瘤 软组织肉瘤 筋膜 肉瘤 流行病学 癌症 皮肤病科 外科 内科学 病理
作者
Imran Baig,Kyle C. Lauck,Quoc‐Bao D. Nguyen
出处
期刊:Journal of The American Academy of Dermatology [Elsevier BV]
卷期号:89 (5): 1054-1056 被引量:4
标识
DOI:10.1016/j.jaad.2023.06.044
摘要

To the Editor: Dermatofibrosarcoma protuberans (DFSP) is a rare, aggressive soft tissue sarcoma that affects the dermis, subcutaneous fat, and, in rare cases, muscle and fascia. Although, the metastatic rate of DFSP is low, the local recurrence rate is estimated to range from 2% to 21%.1Huis In 't Veld E.A. van Coevorden F. Grünhagen D.J. et al.Outcome after surgical treatment of dermatofibrosarcoma protuberans: is clinical follow-up always indicated?.Cancer. 2019; 125: 735-741https://doi.org/10.1002/cncr.31924Crossref PubMed Scopus (29) Google Scholar Negative surgical margins are considered to be the most important prognostic factor for DFSP, as local recurrence can predispose to distant metastases.2Hao X. Billings S.D. Wu F. et al.Dermatofibrosarcoma protuberans: update on the diagnosis and treatment.J Clin Med. 2020; 9: 1752https://doi.org/10.3390/jcm9061752Crossref PubMed Scopus (61) Google Scholar Previous research on DFSP prognosis is centered on small cohorts and case series. We aimed to describe the demographics, tumor characteristics, and interventions of DFSP to determine risk factors for recurrence. We also analyzed the recurrence free survival, defined as time of diagnosis to recurrence or DFSP-specific death, whichever occurred first. Data for 7647 patients with histologically confirmed DFSP (ICD-0-3: codes 8832/8833) were collected from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program (18 registries, 2000-2018). After excluding those with missing information on race, anatomic site, and/or treatment modality, 4451 patients remained and 56 (1.26%) had recurrences. Of the 4451 patients, 52 (1.17%) had a DFSP-specific death. Descriptive demographic data are summarized in Supplementary Table I, available via Mendeley at https://doi.org/10.17632/mgw6hrhxm4.1. Univariate and multivariable logistic regression models were used to determine predictors of recurrence in patients with DFSP. Statistical analyses were conducted using SAS, version 9.4 (SAS Institute). In patients with recurrence, the median original tumor size was 3 cm (3 cm in nonrelapsing patients), and the median age of diagnosis was 42 years old (42 years in nonrelapsing patients). Age, sex, and marital status were significant risk factors in univariate analysis for risk of recurrence/DFSP-specified death (≥45 years: HR, 1.90; 95% CI, 1.29-2.79; P = .001) (unmarried: HR, 1.68; 95% CI, 1.12-2.54; P = .013) (male: HR, 2.32; 95% CI, 1.32-4.10; P = .004), but did not influence the risk in the multivariate analysis (Table I). In the multivariable model assessing for an association between age, sex, race, household income, and size, the risk of recurrence/DFSP-specified death in patients with large tumor size (≥3 cm) was 2.60 (95% CI: 1.30, 5.18) fold higher than in patients with small tumor size (P = .007) (Fig 1).Table IUnivariate proportional hazard Cox regressionVariableCategoryRecurrence/DFSP-specified deathTotalHR (95% CI)P-valueAge<45 y432381Ref≥45 y6520701.90 (1.29, 2.79).001SexFemale442385RefMale6420661.74 (1.19, 2.56).005RaceNon-Hispanic White562535RefOthers5219161.34 (0.92, 1.96).125Marital statusMarried392007RefNot Married5518051.68 (1.12, 2.54).013Household income≥$60,000763332Ref<$60,0003211181.46 (0.96, 2.21).074Anatomic siteTrunk502275RefHead/Neck205621.64 (0.97, 2.75).062Extremities3816141.03 (0.67, 1.57).901Size<3 cm111042Ref≥3 cm3011642.60 (1.30, 5.18).007Surgical modalityExcision933684RefMMS55310.48 (0.19, 1.17).106TreatmentSurgery only933986RefSurgery + Radiation only41940.85 (0.31, 2.31).748 Open table in a new tab Previous studies have had mixed findings on whether tumor size correlates to recurrence.1Huis In 't Veld E.A. van Coevorden F. Grünhagen D.J. et al.Outcome after surgical treatment of dermatofibrosarcoma protuberans: is clinical follow-up always indicated?.Cancer. 2019; 125: 735-741https://doi.org/10.1002/cncr.31924Crossref PubMed Scopus (29) Google Scholar,3Kim M. Huh C.H. Cho K.H. Cho S. A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients.J Eur Acad Dermatol Venereol. 2012; 26: 964-971https://doi.org/10.1111/j.1468-3083.2011.04190.xCrossref PubMed Scopus (20) Google Scholar In a cohort study of 197 patients, Li et al found that larger tumor size (>5 cm) was significantly associated with recurrence in the univariate analysis, but not in multivariate analysis.4Li Y. Wang C. Yang K. et al.Clinical features of dermatofibrosarcoma protuberans and risk factors for local recurrence after Mohs micrographic surgery.J Am Acad Dermatol. 2020; 82: 1219-1221https://doi.org/10.1016/j.jaad.2019.09.034Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar Our larger study suggested a greater tumor size to be significantly associated with recurrence even in multivariate analysis. More recently, Criscito et al5Criscito M.C. Martires K.J. Stein J.A. Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans.JAMA Dermatol. 2016; 152: 1365https://doi.org/10.1001/jamadermatol.2016.1886Crossref PubMed Scopus (51) Google Scholar demonstrated that larger tumor size (>3 cm) is associated with worse overall survival, which supports our findings. Limitations are that the SEER database contains limited data regarding select patient information. Additionally, SEER defines tumor size in some time periods as categorical variables in preset ranges, which may affect our ability to delineate a highly accurate median. However, the primary strength is a relatively large population in a rare disease. Due to the risk of recurrence in DFSP, identifying high risk patient populations is crucial along with careful examination and proactive follow-up. None disclosed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的小迷弟应助lizheng采纳,获得10
刚刚
顺利妖丽发布了新的文献求助20
刚刚
chaserlife发布了新的文献求助10
1秒前
1秒前
咕叽咕叽关注了科研通微信公众号
2秒前
过柱菜鸟完成签到,获得积分10
2秒前
Jasper应助羊丢丢啊丢丢采纳,获得10
2秒前
3秒前
3秒前
ijn完成签到,获得积分10
4秒前
长情绿凝发布了新的文献求助10
4秒前
5秒前
5秒前
5秒前
彭于晏应助wlei采纳,获得10
5秒前
6秒前
张雨兴完成签到,获得积分10
6秒前
chaserlife完成签到,获得积分10
7秒前
顺利妖丽完成签到,获得积分10
7秒前
FXQ123_范完成签到,获得积分10
8秒前
8秒前
小西发布了新的文献求助10
8秒前
8秒前
wy.he应助好运连连采纳,获得10
8秒前
ijn发布了新的文献求助50
8秒前
hh完成签到,获得积分20
8秒前
我是老大应助qx采纳,获得10
8秒前
叶子完成签到,获得积分10
8秒前
8秒前
8秒前
隐形曼青应助邢凡柔采纳,获得10
9秒前
wendinfgmei发布了新的文献求助10
9秒前
9秒前
嘿嘿发布了新的文献求助10
9秒前
王心茹发布了新的文献求助10
10秒前
汉堡包应助kinn采纳,获得20
10秒前
10秒前
偷喝汽水完成签到,获得积分10
11秒前
丘奇发布了新的文献求助10
11秒前
Sunly发布了新的文献求助10
11秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974358
求助须知:如何正确求助?哪些是违规求助? 3518706
关于积分的说明 11195521
捐赠科研通 3254897
什么是DOI,文献DOI怎么找? 1797614
邀请新用户注册赠送积分活动 877011
科研通“疑难数据库(出版商)”最低求助积分说明 806128